MYO - חוב כולל להון Myomo

The current price chart for Myomo, Inc. (MYO) illustrates the financial profile of the exoskeleton manufacturer, whose stable margins are supported by global distribution and reliable component suppliers. The total debt-to-equity ratio stands at 3.65 as the company captures a niche market for myoelectric devices designed for upper-limb functional restoration. The business is expanding its influence through strategic alliances with specialized medical centers, implementing robotic mobility recovery systems.

Operating cash flow dynamics directly impact the debt-to-equity ratio, reflecting the extent of the business's reliance on external creditors to maintain liquidity. For Myomo, Inc., which is scaling the deployment of robotic orthoses through clinic partnerships, the financial leverage of total debt-to-equity demonstrates a balance between investments in rehabilitation technologies and the company's financial stability.